Back to PollNow

Back to companies

iBio, Inc.

IBIOUSNASDAQPharmaceuticals & Healthcare

iBio, Inc.

Revenue

$100,000

FY2026

Operating income

-$35.1mn

FY2026

Employees

—

Founded

—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API